1. Home
  2. MNKD vs SBGI Comparison

MNKD vs SBGI Comparison

Compare MNKD & SBGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MannKind Corporation

MNKD

MannKind Corporation

HOLD

Current Price

$4.26

Market Cap

1.2B

Sector

Health Care

ML Signal

HOLD

Logo Sinclair Inc.

SBGI

Sinclair Inc.

HOLD

Current Price

$14.32

Market Cap

998.0M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
MNKD
SBGI
Founded
1991
1986
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Broadcasting
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
998.0M
IPO Year
2004
2023

Fundamental Metrics

Financial Performance
Metric
MNKD
SBGI
Price
$4.26
$14.32
Analyst Decision
Buy
Buy
Analyst Count
8
5
Target Price
$8.69
$22.00
AVG Volume (30 Days)
4.9M
508.4K
Earning Date
05-06-2026
04-30-2026
Dividend Yield
N/A
6.56%
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$348,966,000.00
$3,169,000,000.00
Revenue This Year
$35.81
$12.37
Revenue Next Year
$11.89
N/A
P/E Ratio
N/A
N/A
Revenue Growth
22.23
N/A
52 Week Low
$2.23
$12.46
52 Week High
$6.51
$17.88

Technical Indicators

Market Signals
Indicator
MNKD
SBGI
Relative Strength Index (RSI) 57.43 51.87
Support Level $3.74 $13.13
Resistance Level $4.55 $14.81
Average True Range (ATR) 0.21 0.66
MACD 0.04 0.05
Stochastic Oscillator 83.12 34.91

Price Performance

Historical Comparison
MNKD
SBGI

About MNKD MannKind Corporation

MannKind Corp is a biopharmaceutical company focused on the development and commercialization of patient-centric therapies that address serious unmet medical needs for those living with cardiometabolic and orphan lung diseases. The Company is currently commercializing three products: Afrezza (insulin human) Inhalation Powder, an ultra rapid-acting inhaled insulin indicated to improve glycemic control in adults with diabetes; Furoscix (furosemide injection), to treat fluid buildup in patients with chronic heart failure or chronic kidney disease; and the V-Go wearable insulin delivery device, which provides continuous subcutaneous infusion of insulin in adults that require insulin.

About SBGI Sinclair Inc.

Sinclair Inc. is the owner-operator of the second largest portfolio of television stations in the United States, with 185 full power stations in 86 markets, covering 40% of US households. Of the firm's roughly 600 channels, 150 are affiliated with the four national broadcasters—Fox, ABC, CBS, and NBC—with over 80 other channels aligned with The CW (Nexstar) and MyNetworkTV (Fox). Sinclair owns the Tennis Channel and stakes in Marquee Sports Network and YES Network, providing their premium sports content to pay-TV distributors.

Share on Social Networks: